Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 2Phase 1/2 2Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 6Genitourinary 4Gastrointestinal 4Head & Neck 3Sarcoma 2Gynecologic 2Thoracic 1Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Carcinoma, Basal Cell 1

Interventions

Blood Specimen Collection 16Cyclophosphamide 11fludarabine phosphate 10Peripheral Blood Stem Cell Transplantation 10Cyclosporine 10Photochemotherapy 9Biopsy 9Whole-Body Irradiation 8Standard of Care 8Radiotherapy 8Educational Status 8Surgical Procedures, Operative 7Radiosurgery 7Mycophenolic Acid 7Early Intervention, Educational 7Aminolevulinic Acid 7Tomography, Optical Coherence 6Surveys and Questionnaires 6Psychiatric Rehabilitation 6Practice Guidelines as Topic 6Methods 6Melphalan 6Filgrastim 6Busulfan 5Antilymphocyte Serum 5methyl 5-aminolevulinate 4Therapeutics 4Sentinel Lymph Node Biopsy 4Mohs Surgery 4Microscopy, Confocal 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Gene Expression Profiling × Dermatologic × Clear all
NCT00644384 2011-05-16

Acitretin in Preventing Skin Cancer in Patients at High Risk for Skin Cancer

Mayo Clinic

Phase NA Completed
130 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡